The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study

Introduction Medicines acting on the central nervous system can increase the risk of postoperative delirium, but the specific medicines associated with greatest risk remain unclear. Objectives We aimed to examine the risk of individual central nervous system-acting medicines used preoperatively on d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug safety 2022, Vol.45 (1), p.75-82
Hauptverfasser: Kassie, Gizat M., Roughead, Elizabeth E., Nguyen, Tuan A., Pratt, Nicole L., Kalisch Ellett, Lisa M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 82
container_issue 1
container_start_page 75
container_title Drug safety
container_volume 45
creator Kassie, Gizat M.
Roughead, Elizabeth E.
Nguyen, Tuan A.
Pratt, Nicole L.
Kalisch Ellett, Lisa M.
description Introduction Medicines acting on the central nervous system can increase the risk of postoperative delirium, but the specific medicines associated with greatest risk remain unclear. Objectives We aimed to examine the risk of individual central nervous system-acting medicines used preoperatively on delirium after hip or knee surgery. Methods A matched case-control study was conducted using data from the Australian Government Department of Veterans’ Affairs. We included people aged 65 years or older who had knee or hip surgery between 2000 and 2019. People with hip or knee surgery who developed postoperative delirium were cases and controls were people with hip or knee surgery but who did not develop postoperative delirium. Use of medicines including anxiolytics, sedatives, and hypnotics, opioid analgesics and antidepressants prior to surgery was compared between cases and controls. Results A total of 2614 patient cases with postoperative delirium were matched by same sex, age (±2 years), and year of admission (±2 years) with 7842 controls without postoperative delirium. Cases were more likely to be exposed to nitrazepam (odds ratio [OR] = 1.81, 95% confidence interval [CI] 1.24–2.64), sertraline (OR = 1.50, 95% CI 1.20–1.87), mirtazapine (OR = 1.38, 95% CI 1.11–1.74), venlafaxine (OR = 1.42, 95% CI 1.02–1.98), citalopram (OR = 1.54, 95% CI 1.19–1.99), escitalopram (OR = 1.42, 95% CI 1.06–1.89) or fluvoxamine (OR = 5.01, 95% CI 2.15–11.68) prior to surgery than controls. At the class level, exposure to benzodiazepines (OR = 1.20, 95% CI 1.05–1.37) and antidepressants (OR = 1.64, 95% CI 1.47–1.83) prior to surgery was significantly higher in cases than in controls. The numbers needed to treat to harm for one additional delirium case were 43 for sertraline, 40 for citalopram, 57 for mirtazapine and 26 for nitrazepam. Whereas, the numbers needed to treat to harm were found to be 20 for sertraline, 17 for citalopram, 19 for mirtazapine and 10 for nitrazepam in the 85 years or older age group, indicating that the harmful effect of these medicines is pronounced as age advances. Conclusions People who developed delirium following hip or knee surgery were more likely to be exposed to nitrazepam, sertraline, mirtazapine, venlafaxine, citalopram, escitalopram or fluvoxamine at the time of admission for surgery. Planning to reduce use of these medicines well prior to surgery may decrease the risk of postoperative delirium.
doi_str_mv 10.1007/s40264-021-01136-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2622303805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2622303805</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-f24b72fef9689ab45bcc6f052cee4e06f24d1e0fe88145f0a70434902556dd5f3</originalsourceid><addsrcrecordid>eNp9kMFO3DAQhq2qqGwpL9BDNVLPbseO7STcVgFKBRTUhbOVTcYQmo0XO6HaV-hTY7oUbj2NNPPN_0sfYx8FfhGI-deoUBrFUQqOQmSGizdsJkReclEq-ZbN0lZxXQqzy97HeIeIhTTFO7abqVwVoixn7M_VLcHPLv4C7-AykF9TqMfugaCiYQx1Dz8oPPgpwmITR1rxeTN2ww2cU9s1CfRDBD_AIfVd6KYVHPu-97-fiJNuDT7A6UAEiyncUNgcwBzO67G5pRaqOhKvfOrwPSzGqd18YDuu7iPtP889dn18dFWd8LOLb9-r-RlvslyP3Em1zKUjV5qirJdKL5vGONSyIVKEJt1bQeioKITSDuscVaZKlFqbttUu22Oft7nr4O8niqO981MYUqWVRsoMswJ1ouSWaoKPMZCz69Ct6rCxAu2TfrvVb5N--1e_Fenp03P0tFxR-_Lyz3cCsi0Q02lITl67_xP7CAEvkNc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2622303805</pqid></control><display><type>article</type><title>The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study</title><source>MEDLINE</source><source>Springer Online Journals Complete</source><creator>Kassie, Gizat M. ; Roughead, Elizabeth E. ; Nguyen, Tuan A. ; Pratt, Nicole L. ; Kalisch Ellett, Lisa M.</creator><creatorcontrib>Kassie, Gizat M. ; Roughead, Elizabeth E. ; Nguyen, Tuan A. ; Pratt, Nicole L. ; Kalisch Ellett, Lisa M.</creatorcontrib><description>Introduction Medicines acting on the central nervous system can increase the risk of postoperative delirium, but the specific medicines associated with greatest risk remain unclear. Objectives We aimed to examine the risk of individual central nervous system-acting medicines used preoperatively on delirium after hip or knee surgery. Methods A matched case-control study was conducted using data from the Australian Government Department of Veterans’ Affairs. We included people aged 65 years or older who had knee or hip surgery between 2000 and 2019. People with hip or knee surgery who developed postoperative delirium were cases and controls were people with hip or knee surgery but who did not develop postoperative delirium. Use of medicines including anxiolytics, sedatives, and hypnotics, opioid analgesics and antidepressants prior to surgery was compared between cases and controls. Results A total of 2614 patient cases with postoperative delirium were matched by same sex, age (±2 years), and year of admission (±2 years) with 7842 controls without postoperative delirium. Cases were more likely to be exposed to nitrazepam (odds ratio [OR] = 1.81, 95% confidence interval [CI] 1.24–2.64), sertraline (OR = 1.50, 95% CI 1.20–1.87), mirtazapine (OR = 1.38, 95% CI 1.11–1.74), venlafaxine (OR = 1.42, 95% CI 1.02–1.98), citalopram (OR = 1.54, 95% CI 1.19–1.99), escitalopram (OR = 1.42, 95% CI 1.06–1.89) or fluvoxamine (OR = 5.01, 95% CI 2.15–11.68) prior to surgery than controls. At the class level, exposure to benzodiazepines (OR = 1.20, 95% CI 1.05–1.37) and antidepressants (OR = 1.64, 95% CI 1.47–1.83) prior to surgery was significantly higher in cases than in controls. The numbers needed to treat to harm for one additional delirium case were 43 for sertraline, 40 for citalopram, 57 for mirtazapine and 26 for nitrazepam. Whereas, the numbers needed to treat to harm were found to be 20 for sertraline, 17 for citalopram, 19 for mirtazapine and 10 for nitrazepam in the 85 years or older age group, indicating that the harmful effect of these medicines is pronounced as age advances. Conclusions People who developed delirium following hip or knee surgery were more likely to be exposed to nitrazepam, sertraline, mirtazapine, venlafaxine, citalopram, escitalopram or fluvoxamine at the time of admission for surgery. Planning to reduce use of these medicines well prior to surgery may decrease the risk of postoperative delirium.</description><identifier>ISSN: 0114-5916</identifier><identifier>EISSN: 1179-1942</identifier><identifier>DOI: 10.1007/s40264-021-01136-1</identifier><identifier>PMID: 34748199</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Age ; Aged ; Analgesics ; Antidepressants ; Antidepressive Agents - adverse effects ; Anxiolytics ; Australia - epidemiology ; Benzodiazepines ; Case-Control Studies ; Central Nervous System ; Citalopram ; Codes ; Confidence intervals ; Delirium ; Delirium - chemically induced ; Delirium - epidemiology ; Dementia ; Drug Safety and Pharmacovigilance ; Ethics ; Exposure ; Fluvoxamine ; Fractures ; Hip ; Hospitalization ; Hospitals ; Humans ; Hypnotics ; Joint surgery ; Knee ; Medicine ; Medicine &amp; Public Health ; Mental disorders ; Mirtazapine ; Mortality ; Narcotics ; Nervous system ; Nitrazepam ; Older people ; Opioids ; Original Research Article ; Patients ; Pharmacology/Toxicology ; Population ; Psychotropic drugs ; Risk ; Risk Factors ; Sedatives ; Sertraline ; Socioeconomic factors ; Surgery ; Systematic review ; Venlafaxine ; Venlafaxine Hydrochloride</subject><ispartof>Drug safety, 2022, Vol.45 (1), p.75-82</ispartof><rights>Crown 2021</rights><rights>2021. Crown.</rights><rights>Copyright Springer Nature B.V. Jan 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-f24b72fef9689ab45bcc6f052cee4e06f24d1e0fe88145f0a70434902556dd5f3</citedby><cites>FETCH-LOGICAL-c375t-f24b72fef9689ab45bcc6f052cee4e06f24d1e0fe88145f0a70434902556dd5f3</cites><orcidid>0000-0003-4286-3771</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40264-021-01136-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40264-021-01136-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34748199$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kassie, Gizat M.</creatorcontrib><creatorcontrib>Roughead, Elizabeth E.</creatorcontrib><creatorcontrib>Nguyen, Tuan A.</creatorcontrib><creatorcontrib>Pratt, Nicole L.</creatorcontrib><creatorcontrib>Kalisch Ellett, Lisa M.</creatorcontrib><title>The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study</title><title>Drug safety</title><addtitle>Drug Saf</addtitle><addtitle>Drug Saf</addtitle><description>Introduction Medicines acting on the central nervous system can increase the risk of postoperative delirium, but the specific medicines associated with greatest risk remain unclear. Objectives We aimed to examine the risk of individual central nervous system-acting medicines used preoperatively on delirium after hip or knee surgery. Methods A matched case-control study was conducted using data from the Australian Government Department of Veterans’ Affairs. We included people aged 65 years or older who had knee or hip surgery between 2000 and 2019. People with hip or knee surgery who developed postoperative delirium were cases and controls were people with hip or knee surgery but who did not develop postoperative delirium. Use of medicines including anxiolytics, sedatives, and hypnotics, opioid analgesics and antidepressants prior to surgery was compared between cases and controls. Results A total of 2614 patient cases with postoperative delirium were matched by same sex, age (±2 years), and year of admission (±2 years) with 7842 controls without postoperative delirium. Cases were more likely to be exposed to nitrazepam (odds ratio [OR] = 1.81, 95% confidence interval [CI] 1.24–2.64), sertraline (OR = 1.50, 95% CI 1.20–1.87), mirtazapine (OR = 1.38, 95% CI 1.11–1.74), venlafaxine (OR = 1.42, 95% CI 1.02–1.98), citalopram (OR = 1.54, 95% CI 1.19–1.99), escitalopram (OR = 1.42, 95% CI 1.06–1.89) or fluvoxamine (OR = 5.01, 95% CI 2.15–11.68) prior to surgery than controls. At the class level, exposure to benzodiazepines (OR = 1.20, 95% CI 1.05–1.37) and antidepressants (OR = 1.64, 95% CI 1.47–1.83) prior to surgery was significantly higher in cases than in controls. The numbers needed to treat to harm for one additional delirium case were 43 for sertraline, 40 for citalopram, 57 for mirtazapine and 26 for nitrazepam. Whereas, the numbers needed to treat to harm were found to be 20 for sertraline, 17 for citalopram, 19 for mirtazapine and 10 for nitrazepam in the 85 years or older age group, indicating that the harmful effect of these medicines is pronounced as age advances. Conclusions People who developed delirium following hip or knee surgery were more likely to be exposed to nitrazepam, sertraline, mirtazapine, venlafaxine, citalopram, escitalopram or fluvoxamine at the time of admission for surgery. Planning to reduce use of these medicines well prior to surgery may decrease the risk of postoperative delirium.</description><subject>Age</subject><subject>Aged</subject><subject>Analgesics</subject><subject>Antidepressants</subject><subject>Antidepressive Agents - adverse effects</subject><subject>Anxiolytics</subject><subject>Australia - epidemiology</subject><subject>Benzodiazepines</subject><subject>Case-Control Studies</subject><subject>Central Nervous System</subject><subject>Citalopram</subject><subject>Codes</subject><subject>Confidence intervals</subject><subject>Delirium</subject><subject>Delirium - chemically induced</subject><subject>Delirium - epidemiology</subject><subject>Dementia</subject><subject>Drug Safety and Pharmacovigilance</subject><subject>Ethics</subject><subject>Exposure</subject><subject>Fluvoxamine</subject><subject>Fractures</subject><subject>Hip</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypnotics</subject><subject>Joint surgery</subject><subject>Knee</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mental disorders</subject><subject>Mirtazapine</subject><subject>Mortality</subject><subject>Narcotics</subject><subject>Nervous system</subject><subject>Nitrazepam</subject><subject>Older people</subject><subject>Opioids</subject><subject>Original Research Article</subject><subject>Patients</subject><subject>Pharmacology/Toxicology</subject><subject>Population</subject><subject>Psychotropic drugs</subject><subject>Risk</subject><subject>Risk Factors</subject><subject>Sedatives</subject><subject>Sertraline</subject><subject>Socioeconomic factors</subject><subject>Surgery</subject><subject>Systematic review</subject><subject>Venlafaxine</subject><subject>Venlafaxine Hydrochloride</subject><issn>0114-5916</issn><issn>1179-1942</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kMFO3DAQhq2qqGwpL9BDNVLPbseO7STcVgFKBRTUhbOVTcYQmo0XO6HaV-hTY7oUbj2NNPPN_0sfYx8FfhGI-deoUBrFUQqOQmSGizdsJkReclEq-ZbN0lZxXQqzy97HeIeIhTTFO7abqVwVoixn7M_VLcHPLv4C7-AykF9TqMfugaCiYQx1Dz8oPPgpwmITR1rxeTN2ww2cU9s1CfRDBD_AIfVd6KYVHPu-97-fiJNuDT7A6UAEiyncUNgcwBzO67G5pRaqOhKvfOrwPSzGqd18YDuu7iPtP889dn18dFWd8LOLb9-r-RlvslyP3Em1zKUjV5qirJdKL5vGONSyIVKEJt1bQeioKITSDuscVaZKlFqbttUu22Oft7nr4O8niqO981MYUqWVRsoMswJ1ouSWaoKPMZCz69Ct6rCxAu2TfrvVb5N--1e_Fenp03P0tFxR-_Lyz3cCsi0Q02lITl67_xP7CAEvkNc</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Kassie, Gizat M.</creator><creator>Roughead, Elizabeth E.</creator><creator>Nguyen, Tuan A.</creator><creator>Pratt, Nicole L.</creator><creator>Kalisch Ellett, Lisa M.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7T2</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><orcidid>https://orcid.org/0000-0003-4286-3771</orcidid></search><sort><creationdate>2022</creationdate><title>The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study</title><author>Kassie, Gizat M. ; Roughead, Elizabeth E. ; Nguyen, Tuan A. ; Pratt, Nicole L. ; Kalisch Ellett, Lisa M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-f24b72fef9689ab45bcc6f052cee4e06f24d1e0fe88145f0a70434902556dd5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Aged</topic><topic>Analgesics</topic><topic>Antidepressants</topic><topic>Antidepressive Agents - adverse effects</topic><topic>Anxiolytics</topic><topic>Australia - epidemiology</topic><topic>Benzodiazepines</topic><topic>Case-Control Studies</topic><topic>Central Nervous System</topic><topic>Citalopram</topic><topic>Codes</topic><topic>Confidence intervals</topic><topic>Delirium</topic><topic>Delirium - chemically induced</topic><topic>Delirium - epidemiology</topic><topic>Dementia</topic><topic>Drug Safety and Pharmacovigilance</topic><topic>Ethics</topic><topic>Exposure</topic><topic>Fluvoxamine</topic><topic>Fractures</topic><topic>Hip</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypnotics</topic><topic>Joint surgery</topic><topic>Knee</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mental disorders</topic><topic>Mirtazapine</topic><topic>Mortality</topic><topic>Narcotics</topic><topic>Nervous system</topic><topic>Nitrazepam</topic><topic>Older people</topic><topic>Opioids</topic><topic>Original Research Article</topic><topic>Patients</topic><topic>Pharmacology/Toxicology</topic><topic>Population</topic><topic>Psychotropic drugs</topic><topic>Risk</topic><topic>Risk Factors</topic><topic>Sedatives</topic><topic>Sertraline</topic><topic>Socioeconomic factors</topic><topic>Surgery</topic><topic>Systematic review</topic><topic>Venlafaxine</topic><topic>Venlafaxine Hydrochloride</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kassie, Gizat M.</creatorcontrib><creatorcontrib>Roughead, Elizabeth E.</creatorcontrib><creatorcontrib>Nguyen, Tuan A.</creatorcontrib><creatorcontrib>Pratt, Nicole L.</creatorcontrib><creatorcontrib>Kalisch Ellett, Lisa M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kassie, Gizat M.</au><au>Roughead, Elizabeth E.</au><au>Nguyen, Tuan A.</au><au>Pratt, Nicole L.</au><au>Kalisch Ellett, Lisa M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study</atitle><jtitle>Drug safety</jtitle><stitle>Drug Saf</stitle><addtitle>Drug Saf</addtitle><date>2022</date><risdate>2022</risdate><volume>45</volume><issue>1</issue><spage>75</spage><epage>82</epage><pages>75-82</pages><issn>0114-5916</issn><eissn>1179-1942</eissn><abstract>Introduction Medicines acting on the central nervous system can increase the risk of postoperative delirium, but the specific medicines associated with greatest risk remain unclear. Objectives We aimed to examine the risk of individual central nervous system-acting medicines used preoperatively on delirium after hip or knee surgery. Methods A matched case-control study was conducted using data from the Australian Government Department of Veterans’ Affairs. We included people aged 65 years or older who had knee or hip surgery between 2000 and 2019. People with hip or knee surgery who developed postoperative delirium were cases and controls were people with hip or knee surgery but who did not develop postoperative delirium. Use of medicines including anxiolytics, sedatives, and hypnotics, opioid analgesics and antidepressants prior to surgery was compared between cases and controls. Results A total of 2614 patient cases with postoperative delirium were matched by same sex, age (±2 years), and year of admission (±2 years) with 7842 controls without postoperative delirium. Cases were more likely to be exposed to nitrazepam (odds ratio [OR] = 1.81, 95% confidence interval [CI] 1.24–2.64), sertraline (OR = 1.50, 95% CI 1.20–1.87), mirtazapine (OR = 1.38, 95% CI 1.11–1.74), venlafaxine (OR = 1.42, 95% CI 1.02–1.98), citalopram (OR = 1.54, 95% CI 1.19–1.99), escitalopram (OR = 1.42, 95% CI 1.06–1.89) or fluvoxamine (OR = 5.01, 95% CI 2.15–11.68) prior to surgery than controls. At the class level, exposure to benzodiazepines (OR = 1.20, 95% CI 1.05–1.37) and antidepressants (OR = 1.64, 95% CI 1.47–1.83) prior to surgery was significantly higher in cases than in controls. The numbers needed to treat to harm for one additional delirium case were 43 for sertraline, 40 for citalopram, 57 for mirtazapine and 26 for nitrazepam. Whereas, the numbers needed to treat to harm were found to be 20 for sertraline, 17 for citalopram, 19 for mirtazapine and 10 for nitrazepam in the 85 years or older age group, indicating that the harmful effect of these medicines is pronounced as age advances. Conclusions People who developed delirium following hip or knee surgery were more likely to be exposed to nitrazepam, sertraline, mirtazapine, venlafaxine, citalopram, escitalopram or fluvoxamine at the time of admission for surgery. Planning to reduce use of these medicines well prior to surgery may decrease the risk of postoperative delirium.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>34748199</pmid><doi>10.1007/s40264-021-01136-1</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4286-3771</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0114-5916
ispartof Drug safety, 2022, Vol.45 (1), p.75-82
issn 0114-5916
1179-1942
language eng
recordid cdi_proquest_journals_2622303805
source MEDLINE; Springer Online Journals Complete
subjects Age
Aged
Analgesics
Antidepressants
Antidepressive Agents - adverse effects
Anxiolytics
Australia - epidemiology
Benzodiazepines
Case-Control Studies
Central Nervous System
Citalopram
Codes
Confidence intervals
Delirium
Delirium - chemically induced
Delirium - epidemiology
Dementia
Drug Safety and Pharmacovigilance
Ethics
Exposure
Fluvoxamine
Fractures
Hip
Hospitalization
Hospitals
Humans
Hypnotics
Joint surgery
Knee
Medicine
Medicine & Public Health
Mental disorders
Mirtazapine
Mortality
Narcotics
Nervous system
Nitrazepam
Older people
Opioids
Original Research Article
Patients
Pharmacology/Toxicology
Population
Psychotropic drugs
Risk
Risk Factors
Sedatives
Sertraline
Socioeconomic factors
Surgery
Systematic review
Venlafaxine
Venlafaxine Hydrochloride
title The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T15%3A36%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Risk%20of%20Preoperative%20Central%20Nervous%20System-Acting%20Medications%20on%20Delirium%20Following%20Hip%20or%20Knee%20Surgery:%20A%20Matched%20Case-Control%20Study&rft.jtitle=Drug%20safety&rft.au=Kassie,%20Gizat%20M.&rft.date=2022&rft.volume=45&rft.issue=1&rft.spage=75&rft.epage=82&rft.pages=75-82&rft.issn=0114-5916&rft.eissn=1179-1942&rft_id=info:doi/10.1007/s40264-021-01136-1&rft_dat=%3Cproquest_cross%3E2622303805%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2622303805&rft_id=info:pmid/34748199&rfr_iscdi=true